29 Sep 2020,
  • HSI:
    24,781.58 -125.76 (-0.50%)
    HSCI:
    9,980.30 -13.18 (-0.13%)
    HKSPLC25:
    36,045.52 13.33 (0.04%)
    HKSPGEM:
    88.03 -1.02 (-1.15%)
  • HSCEI:
    9,897.03 -39.63 (-0.40%)
    HSCCI:
    3,756.57 -5.40 (-0.14%)
    HSFML25:
    8,614.22 1.26 (0.01%)
    H-FIN:
    14,563.34 -16.49 (-0.11%)
  • Hang Seng Index
  • 24,781.58

  • -125.76 (-0.50%)
HSCI 9,980.3 -13.2
HKSPLC25 36,045.5 13.3
HKSPGEM 88.0 -1.0
HSCEI 9,897.0 -39.6
HSCCI 3,756.6 -5.4
HSFML25 8,614.2 1.3
H-FIN 14,563.3 -16.5
Stay Connected With EQS TodayIR

Tianda Pharmaceuticals Limited (00455.HK)

Health Care
+ More Circulars

INTRADAY CHART

more

FINANCIAL REPORTSmore

2020 (AR)
2019 (IR)
2019 (AR)

PRESENTATIONSmore

  • 2013/14 Annua ...
    2014
  • 2013 Interim ...
    2013
  • 2012/13 Annua ...
    2013
Tianda Pharmaceuticals Ltd (Tianda Pharmaceuticals) is engaged in the research and development, manufacture and sales of pharmaceutical, biotechnology and healthcare products.

Headquartered in Hong Kong, Tianda Pharmaceuticals has set up sales and distribution centres in Shenzhen and Sydney, and established two pharmaceutical R&D and production bases in Zhuhai and Kunming. Both production bases are awarded Good Manufacturing Practice ("GMP") certifications issued by China Food and Drug Administration ("CFDA"). The production base in Zhuhai is even awarded GMP certification by Therapeutic Goods Administration ("TGA") of Australia.

Tianda Pharmaceuticals is listed on the Hong Kong Stock Exchange (Stock Code: 00455.HK). Tianda Group is its controlling stakeholder with a 55.56% stake.
+ More Company Profile

Mr. Alan Fang -

Mr. Fang is Executive Director, Chairman and Managing Director, the chairman of the nomination committee and a member of the remuneration committee and the risk management committee of Tianda Pharmaceuticals Limited, as well as a director of certain subsidiaries of Tianda Pharmaceuticals Limited. Mr. Fang is the founder, chairman and beneficial owner of Tianda Group Limited, the controlling shareholder of Tianda Pharmaceuticals Limited. Mr. Fang is also the existing chairman of the board of directors, General Manager and authorized representative of Tianda Culture Holdings (China) Limited (listed on the National Equities Exchange and Quotations Systems, company code: 837889). He has ample experience in corporate strategy and management. He established a non-profit strategic studies think tank named “Tianda Institute”. Upholding the mission of “Caring for a Better World”, Mr. Fang always shows his greater commitment to community services, including donations to the poverties, education and talent development, healthcare, scientific research and environmental protection, culture and arts.

Mr. Warwick Lui -

Mr. Lui is Executive Director of Tianda Pharmaceuticals Limited and Deputy General Manager of Tianda Group Limited, taking responsibility for the financial management of Tianda Group Limited and Tianda Pharmaceuticals Limited. Mr. Lui has extensive experience in financial management across diverse industries, including auditing in one of the Big Four accounting firms in Hong Kong and taking charge of the finance department of a Hong Kong-listed company. Mr. Lui obtained his Executive Master of Business Administration degree from City University of Hong Kong. He is a fellow member of the Association of Chartered Certified Accountants and the Hong Kong Institute of Certified Public Accountants.

Mr. Raymond Wong -

Mr. Wong is Financial Controller of Tianda Pharmaceuticals Limited, taking responsibility for the company’s financial management and capital operation. Mr. Wong has extensive experience in financing, mergers and acquisitions, compliance, corporate operations and strategy. Mr. Wong worked in audit in one of the Big Four accounting firms in Hong Kong and served as Chief Financial Officer or Financial Controller for various listed and private enterprises in Hong Kong and Singapore. Mr. Wong obtained his Master of Business Administration degree from The University of Hong Kong. He is a fellow member of the Association of Chartered Certified Accountants and a member of the Hong Kong Institute of Certified Public Accountants.

Dr. Wang Weibin -

Dr. Wang is Executive Deputy General Manager of Tianda Pharmaceuticals Limited, assisting Managing Director in the company’s overall management. Dr. Wang has been working in pharmaceutical enterprises all along, gaining extensive experience in strategy planning, sales and marketing, capital operation, merger and acquisition, product R&D, enterprise operation and financial management, etc. He held senior management positions with listed companies on the Shenzhen Stock Exchange, Nasdaq, and the Hong Kong Stock Exchange. Dr. Wang obtained his Executive Master of Business Administration degree and Executive Doctorate of Business Administration degree from United Business Institutes.

Mr. Wang Jiarun -

Mr. Wang is Executive Deputy General Manager of Tianda Pharmaceuticals (China) Limited, taking responsibility for marketing and sales in mainland China. Mr. Wang has solid experience in clinician, pharmaceutical marketing management and operation. Mr. Wang held senior management positions with a number of pharmaceutical companies in China. Mr. Wang obtained his Bachelor’s degree in medicine from Chengdu University of Traditional Chinese Medicine.

Mr. Qian Kun -

Mr. Qian is Executive Deputy General Manager of Tianda Pharmaceuticals (Zhuhai) Limited, taking responsibility for the company’s overall management and the construction of the new plant in Zhuhai. Mr. Qian has extensive experience in pharmaceutical procurement, R&D, manufacturing, plant construction and operation management. He held senior management position with a renowned domestic pharmaceutical company. Mr. Qian obtained his Bachelor's degree in Chinese medicine from Nanjing University of Chinese Medicine and his Master's degree in clinical pharmacy from Soochow University.

Ms. Wu Sujie -

Ms. Wu is Executive Deputy General Manager of Yunnan Meng Sheng Pharmaceutical Company Limited, taking responsibility for the company’s overall management. Ms. Wu has extensive experience in management of drug quality, R&D, drug administration, material logistics, etc. She held senior management positions with foreign-owned enterprises and domestic listed pharmaceutical companies. During her employment, Ms. Wu’s team succeeded several times in getting the Australian Good Manufacturing Practice (“GMP”) certification and the new version Chinese GMP certification. She obtained her Bachelor’s degree in biology from Shaanxi Normal University. She is a senior pharmaceutical engineer and a licensed pharmacist.

Ms. Jenny Yeung -

Ms. Yeung is Chief Executive Officer of TDMall (Group) Limited, assisting Managing Director in the company’s overall operation and management. She is a registered Chinese medicine practitioner with extensive clinical experience. Ms. Yeung obtained her Bachelor’s degree in Chinese Medicine and Bachelor of Science (Hons) in Biomedical Science, and her Master’s degree in Chinese medicine (Internal medicine) from Hong Kong Baptist University. She is now pursuing a PhD in Chinese Medicine at the Chinese University of Hong Kong.

Mr. Di Ming -

Mr. Di is General Manager of Tianda Chinese Medicine (China) Limited, taking responsibility for the company’s overall operation and management. He has extensive experience in Chinese medicinal materials including industry trend and information analysis, varieties research, planting and breeding, operation, trading platform construction, capital operation, etc. He held senior management positions with domestic Chinese medicine information companies, Chinese medicine trading platform companies and listed pharmaceutical companies. Mr. Di graduated from Bengbu Medical College, and obtained his Bachelor's degree from Market Economy Academy of Peking University.

Ms. Yang Yuhua -

Ms. Yang is Senior Deputy General Manager of Zhuhai Tianda Chinese Medicine Institute Development Limited, taking responsibility for the technology and product R&D of Chinese medicine as well as the construction of Chinese medicine research institution platform. Ms. Yang has extensive experience in drug R&D, technology, standards, registration, project management, etc. She held senior management positions with large-scale domestic listed pharmaceutical companies, where she led a number of major national and provincial technology projects, and achieved successful outcomes and garnered numerous awards. . Ms. Yang obtained her Bachelor’s degree in medicine from the School of Pharmacy of Xi'an Medical University, and her Master’s degree from the School of Pharmacy of Lanzhou University. She is a professor-level senior engineer and a licensed pharmacist.

Ms. Xie Bin -

Ms. Xie is Deputy General Manager of Tianda Pharmaceuticals (Zhuhai) Limited, taking responsibility for new drug R&D. Ms. Xie has extensive experience in drug R&D, production quality management and pharmaceutical factory management. She held senior management positions with foreign-owned enterprises and domestic listed pharmaceutical companies. Ms. Xie obtained her Master’s degree in medicine from Changchun University of Chinese Medicine. She is a senior pharmaceutical engineer and a licensed pharmacist.

Mr. Yan Daishan -

Mr. Yan is Deputy General Manager of Zhuhai Tianda Processed Chinese Herbal Medicine Limited, taking responsibility for the company’s overall management. Mr. Yan has extensive experience in the preparation, processing, manufacturing, technology, quality control and product development of TCM decoction pieces as well as construction of processed Chinese herbal medicine factories. He held senior management positions in various processed Chinese herbal medicine companies. Mr. Yan obtained his Bachelor’s degree in Chinese Medicine from Guangxi University of Chinese Medicine, and obtained the certificate of Senior Business Administration course from Renmin University of China College of Continuing Education. He is a licensed pharmacist (TCM).
+ More Board of Directors
Audit Committee

The management staff are properly serving their roles and responsibilities by reviewing and monitoring the duties of the appointed auditor on the basis of independence, objective and validity; examining the annual and interim Financial Statements before submission for Board of Directors ‘approval; and reviewing the financial control, internal audit and risk management system of the company.

Audit Committee Members
Mr. Lam Yat Fai– INED (Chairman)
Mr. Shen Bo– NED
Mr. Chiu Sung Hong– INED
Mr. Chiu Fan Wa– INED

 
Nomination Committee

Set up to nominate, review and discuss about candidacy for Board of Directors, evaluate the independence of the Independent Non-Executive Director and propose appointment to the Board of Directors.

Nomination Committee Members
Mr. Fang Wen Quan – Executive Director (Chairman)
Mr. Lam Yat Fai – INED
Mr. Chiu Sung Hong– INED

 
Risk Management Committee

Set up to assist the Board of Directors to take heed of and make informed decision on operational risks, design the risk management strategy direction and risk control management system in an attempt to reduce the operational risk to the minimum.

Risk Management Committee members
Mr. Chiu Sung Hong – INED (Chairman)
Mr. Fang Wen Quan – Executive Director
Mr. Lam Yat Fai – INED

 
Remuneration Committee

Set up to propose the remuneration policy and framework for Directors and senior management staff.

Remuneration Committee Members
Mr. Chiu Sung Hong –INED(Chairman)
Mr. Fang Wen Quan – Non-Executive Director
Mr. Lam Yat Fai –INED
Mr. Chiu Fan Wa –INED

 
 
 

UPCOMING EVENT

S M T W T F S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

COMPANY INFORMATION

Listed Date 30 Mar 1992

Address Level 24, CITIC Tower,
No. 1 Tim Mei Avenue,
Central, Hong Kong

Telephone (852) 2545-3313

Facsimile (852) 2545-6558

Email info@tianda.com

No. of Click Rate

353572